Sunshine Healthcare appoints T. Sayandhan as CEO of Lina Manufacturing
Sunshine Healthcare has appointed Mr. T. Sayandhan as the Chief Executive Officer of Lina Manufacturing, the pharmaceutical manufacturing segment of the diversified company. Sayandhan, currently CEO of Sunshine Medical Devices, has more than 30 years of experience in the healthcare industry. He joined Sunshine Healthcare in 2017 to spearhead Sunshine Medical Devices and has been instrumental in growing the healthcare business to be the key driver of the Group’s financial performance, helping Sunshine Healthcare to sustain its growth over the few years amidst tough macroeconomic conditions.
Commenting on the new appointment, Sunshine Healthcare Managing Director Shyam Sathasivam said, “As a responsible Sri Lankan conglomerate, we believe the local production of pharmaceuticals plays a vital role in maintaining the resilience of national healthcare systems. When escalating macroeconomic conditions are putting immense pressure on the local healthcare sector, producing pharmaceuticals locally will facilitate access to needed medicines and decrease exposure to imports and international supply chains. At this critical juncture, I believe Sayandhan has demonstrated the right combination of talent and drive to step into this key leadership role at the company.”
Commenting on his appointment, Sayandhan said, “It is a challenging yet exciting time to join Lina Manufacturing when the company is advancing its efforts to develop Sri Lankan-made, innovative healthcare solutions. For over a decade, Lina manufacturing has used its R&D acumen to develop pharmaceutical products for both the public and private sectors. I am honored and look forward to leading the Lina team to further diversify its locally produced pharmaceuticals portfolio and help widen access to quality medicine to all Sri Lankans.”
Sayandhan started his career with GlaxoSmithKline, where he served for more than ten years as a Medical Rep, Hospital Coordinator, Product Executive, Brand Manager and Category Manager. He then took on an enhanced role at Hemas Pharmaceuticals, serving as Country Manager for Allergan and Abbott Medical Optics. Before joining Sunshine Healthcare, he was the Chief Executive Officer – Healthcare Cluster and Director at Delmege Forsyth. Sayandhan, an Executive Committee Member of Sunshine Holdings PLC, holds an MBA from the University of Peradeniya and is currently reading for his doctorate. Sayandhan is also a Fellow of the Charted Institute of Marketing (UK), Sri Lanka Institute of Marketing and the Institute of Management Sri Lanka.
Lina Manufacturing is Sri Lanka’s first Respiratory Care Research and Manufacturing facility. It manufactures a range of respiratory pharmaceuticals and devices, including Beclovent, Flutivent, Salbuvent, Prazolin, Winterpan and the award-winning Ventohaler inhalers. Lina Spiro is the latest venture focusing on manufacturing the newest technology, metered-dose inhalers (MDI) for respiratory care. It is the only such manufacturer certified to WHO-GMP standards in Sri Lanka, opening doors to international exports.
About Sunshine Healthcare
Sunshine Healthcare is Sri Lanka’s first fully integrated healthcare company from R&D and manufacturing up to retailing of healthcare products, including last-mile distribution across the country for all healthcare products. The company’s segments are Sunshine Pharmaceuticals, Sunshine Medical Devices, Healthguard Pharmacy, Lina Manufacturing and Healthguard Distribution. The company is a subsidiary of Sunshine Holdings PLC, a publicly listed conglomerate contributing to ‘nation-building’ by creating value in vital sectors of the Sri Lankan economy – mainly in the healthcare and consumer sectors, with strategic investments in agribusiness.
